Get Quote

Plant-Based Vaccines

Plant-based vaccines use genetically modified plants to produce antigens, offering a scalable and cost-effective approach to immunization.
Contact Us
Home
Services
Biomedical
Recombinant Vaccine Development
Plant-based Vaccines

Plant-Based Vaccines

MRB Next GenTech specializes in plant-based vaccines, an innovative approach where plants are used to produce antigens. This method offers a cost-effective and scalable alternative to traditional vaccine production. By genetically modifying plants to express viral proteins or other antigens, we can produce high-quality vaccines quickly and efficiently. Our services encompass the entire process, from development and testing to large-scale manufacturing and regulatory compliance.

Benefits:

  • Cost-Effective: Lower production costs compared to traditional methods.
  • Scalable: Easy to scale up production to meet high demand.
  • Rapid Development: Quick adaptation to emerging diseases.
  • Safety: No animal-derived components, reducing risk of contamination.
plant based vaccine image

Key Services:

Plant-Based Vaccines:

  • Introduction: Plant-based vaccines use genetically modified plants to produce vaccine antigens. This approach allows for scalable and cost-effective production, ideal for addressing both seasonal and emerging diseases.
  • Technology: We use recombinant DNA technology to introduce antigen genes into plant cells. The plants produce the antigen, which is then harvested and purified for vaccine formulation.
  • Development Process:
    • Gene Insertion: Introducing the antigen gene into the plant genome.
    • Plant Cultivation: Growing the modified plants under controlled conditions.
    • Extraction and Purification: Harvesting and purifying the antigen.
    • Testing and Manufacturing: Conducting rigorous testing and scaling up production.
  • Case Studies/Examples: Plant-based vaccines have been developed for influenza and Ebola, demonstrating their effectiveness and safety.

Who Should Consider This Service:

  • Pharmaceutical Companies: Companies looking to explore cost-effective and scalable vaccine production methods for both established and emerging infectious diseases.
  • Biotech Firms: Biotech companies interested in advancing vaccine development through innovative plant-based platforms.
  • Public Health Organizations: Organizations seeking sustainable and rapidly deployable vaccine solutions to address global health challenges, particularly in low-resource settings.

Frequently Asked Questions (FAQs)

What are plant-based vaccines?
Vaccines produced using genetically modified plants to express the target antigen.
How does recombinant technology help?
It allows precise insertion of antigen genes into plants, ensuring effective and safe vaccines.
What are the regulatory requirements?
Our vaccines meet global safety and efficacy standards set by regulatory bodies like the FDA and EMA.